Effect of a Sciatic Block (SNB) Combined With a Continuous Femoral Block (CFNB) on Pain Scores After Knee Arthroplasty
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Postoperative pain, Knee arthroplasty, Peripheral nerve blocks, Sciatic nerve block, Femoral nerve block
Eligibility Criteria
Inclusion Criteria:
- Unilateral total knee replacement
Exclusion Criteria:
- Contra-indication for general anesthesia
- Infection on puncture site
- Coagulation disorders
- Pre-existent neuropathies
- Allergies to local anesthetics, paracetamol, diclofenac and tramadol
- Severe dyspepsia
- Less than 50kg weigh
- Body Mass Index (BMI) greater than 40
- American Society of Anesthesiologists (ASA) Physical Status 4 or 5
- Absence of capacity to use the Visual Analog Score (VAS) scale
- Refusal to give informed consent
Sites / Locations
- Centro Hospitalar do Porto, Serviço de Anestesia
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Continuous femoral nerve block (CFNB)
Single shot SNB plus CFNB
A continuous femoral nerve block is performed for peri-operative analgesia and a bolus of 30 ml of ropivacaine 0.375% is injected before induction of general anesthesia and surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in post anesthesia care unit (PACU) and maintained for 48h
A single shot sciatic nerve block (SNB) is performed before surgery with 25ml of 0.2% ropivacaine in addition to the continuous femoral nerve block (CFNB) performed in the control group before induction of general anesthesia and surgery starts. An infusion of 8ml/h of ropivacaine 0.2% is started in Post anesthesia care unit (PACU) and maintained for 48h